Featured Research Search Results
Pfizer Clinical Trials for Metastatic Prostate Cancer are Now Enrolling
Treatment
Men aged 18 years or older with metastatic prostate cancer
Sexual Health and Rehabilitation Online (SHAREonline): An Educational Intervention for Young Women after Cancer
Clinicaltrials.gov identifier:
NCT06458049
Quality of Life
An online study comparing two educational interventions for female cancer survivors experiencing sexual health changes
Testing A Combination Of Vaccines For Cancer Prevention In Lynch Syndrome
Clinicaltrials.gov identifier:
NCT05419011
Prevention
Testing a combination of vaccines for cancer prevention in Lynch syndrome
What Happens to Tissue or Blood Samples you Donate as Part of Research?
Surveys, Registries, Interviews
Survey to share your views on a new method to track research specimens
Pancreatic Cancer Screening Study (CAPS5)
Clinicaltrials.gov identifier:
NCT02000089
Prevention
Screening study for people at high risk for pancreatic cancer
Registry for People at Increased Risk for Pancreatic Cancer
Clinicaltrials.gov identifier:
NCT06151223
Surveys, Registries, Interviews
Study collecting blood samples and imaging records of people at high risk of developing pancreatic cancer
Study of the Drug Olvi-Vec in Women with Ovarian Cancer
Clinicaltrials.gov identifier:
NCT05281471
Treatment
Treatment for women diagnosed with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer or whose cancer did not respond to prior chemotherapy
The American Cancer Society’s “VOICES of Black Women” Observational Study
Surveys, Registries, Interviews
VOICES of Black Women is a study led by the American Cancer Society to better understand cancer and other health conditions among Black women
Understanding Risk Factors for Stomach Cancer in People with Inherited Mutations
Surveys, Registries, Interviews
Online survey on stomach cancer risk for people with an inherited mutation in genes that are linked to an increased risk of certain cancers
Understanding the Emotional and Social Experiences of Individuals Diagnosed with Ovarian Cancer
Surveys, Registries, Interviews
Survey for people diagnosed with ovarian cancer
PATROL Study: Prostate Cancer Screening for People AT Genetic Risk FOr Aggressive Disease
Clinicaltrials.gov identifier:
NCT04472338
Prevention
Screening study for people with a mutation linked to prostate cancer risk
Understanding the Cancer Journey: A Survey of Patient Experiences and Emotional Impact
Surveys, Registries, Interviews
Online survey for people diagnosed with breast, colorectal, gastric or prostate cancer within the past twenty years
The DETECT Study: Detecting Endometrial Cancer in Tampons
Clinicaltrials.gov identifier:
NCT03538665
Prevention
Early detection of endometrial cancer in women over 45 years of age who are undergoing hysterectomy surgery at the University of Alabama
Effectiveness of Lymph Node Mapping to Reduce the Risk of Swelling in the Legs in Patients with Stage I Endometrial Cancer
Clinicaltrials.gov identifier:
NCT05646316
Treatment
People with stage I endometrial cancer who are having a hysterectomy
Registry to Discover New Treatments and Developmental Processes of Colorectal and Endometrial Cancer in Patients with Hereditary Cancer
Clinicaltrials.gov identifier:
NCT06096688
Surveys, Registries, Interviews
Study to collect and save data, cancer samples, and cancer family health histories from people who screen for colorectal endometrial cancer
New Treatment in People with Triple Negative Breast Cancer or Advanced Solid Tumors
Clinicaltrials.gov identifier:
NCT06022029
Treatment
Treatment study for people with triple negative breast cancer, advanced solid tumors or lymphomas
The Phoenix Trial: Cemiplimab for Patients with Localized dMMR Colon Cancer
Clinicaltrials.gov identifier:
NCT05961709
Treatment
This study will examine how well Cemiplimab works for patients with localized colon cancer who have dMMR
Screening Study for Men at High Genetic Risk for Prostate Cancer
Clinicaltrials.gov identifier:
NCT03805919
Prevention
Prostate screening with MRI for men with Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) or a BRCA1, BRCA2, HOXB13, ATM, NBN, TP53, BRIP1, CHEK2, PALB2, RAD51C, RAD51D, or other mutation